{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T22:59:25Z","timestamp":1776898765004,"version":"3.51.2"},"reference-count":107,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.phrs.2019.03.016","type":"journal-article","created":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T12:34:40Z","timestamp":1553258080000},"page":"119-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["A review of gene- and cell-based therapies for familial hypercholesterolemia"],"prefix":"10.1016","volume":"143","author":[{"given":"Saeideh","family":"Hajighasemi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armita","family":"Mahdavi Gorabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Bianconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Pirro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6690-6874","authenticated-orcid":false,"given":"Maciej","family":"Banach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Ahmadi Tafti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u017deljko","family":"Reiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.phrs.2019.03.016_bib0005","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/aje\/kwh237","article-title":"Familial hypercholesterolemia and coronary heart disease: a HuGE association review","volume":"160","author":"Austin","year":"2004","journal-title":"Am. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.phrs.2019.03.016_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5551\/jat.27227","article-title":"Autosomal recessive hypercholesterolemia: a mild phenotype of familial hypercholesterolemia: insight from the kinetic study using stable isotope and animal studies","volume":"22","author":"Tada","year":"2015","journal-title":"J. Atheroscler. Thromb."},{"issue":"4","key":"10.1016\/j.phrs.2019.03.016_bib0015","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1074\/jbc.M114.596445","article-title":"LDL receptor and ApoE are involved in the clearance of ApoM-associated sphingosine 1-phosphate","volume":"290","author":"Kurano","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.phrs.2019.03.016_bib0020","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrcardio.2015.92","article-title":"Management of patients with familial hypercholesterolaemia","volume":"12","author":"Reiner","year":"2015","journal-title":"Nat. Rev. Cardiol."},{"issue":"13","key":"10.1016\/j.phrs.2019.03.016_bib0025","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/eurheartj\/eht015","article-title":"Diagnosis and treatment of familial hypercholesterolaemia","volume":"34","author":"Hovingh","year":"2013","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.phrs.2019.03.016_bib0030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1476-511X-7-7","article-title":"Correlating corneal arcus with atherosclerosis in familial hypercholesterolemia","volume":"7","author":"Zech","year":"2008","journal-title":"Lipids Health Dis."},{"issue":"46","key":"10.1016\/j.phrs.2019.03.016_bib0035","first-page":"2375","article-title":"[Familial hypercholesterolemia]","volume":"137","author":"Windler","year":"2012","journal-title":"Dtsch. Med. Wochenschr."},{"issue":"5","key":"10.1016\/j.phrs.2019.03.016_bib0040","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2169\/internalmedicine.52.8522","article-title":"Familial hypercholesterolemia with multiple large tendinous xanthomas and advanced coronary artery atherosclerosis","volume":"52","author":"Terasaki","year":"2013","journal-title":"Intern. Med."},{"issue":"Suppl. 22","key":"10.1016\/j.phrs.2019.03.016_bib0045","first-page":"1","article-title":"Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration","author":"E.A.S.F.H.S. Collaboration","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phrs.2019.03.016_bib0050","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.atherosclerosis.2018.08.051","article-title":"Overview of the current status of familial hypercholesterolaemia care in over 60 countries - the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)","volume":"277","author":"E.A.S.F.H.S. Collaboration","year":"2018","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.phrs.2019.03.016_bib0055","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.atherosclerosis.2015.09.021","article-title":"Familial hypercholesterolaemia: a global call to arms","volume":"243","author":"Vallejo-Vaz","year":"2015","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.phrs.2019.03.016_bib0060","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.jacl.2016.04.009","article-title":"Familial hypercholesterolemia\/autosomal dominant hypercholesterolemia: molecular defects, the LDL-C continuum, and gradients of phenotypic severity","volume":"10","author":"Foody","year":"2016","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.phrs.2019.03.016_bib0065","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.atherosclerosis.2018.01.034","article-title":"A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry)","volume":"270","author":"Kayikcioglu","year":"2018","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.phrs.2019.03.016_bib0070","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S2213-8587(16)30041-9","volume":"4","author":"Santos","year":"2016","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"1","key":"10.1016\/j.phrs.2019.03.016_bib0075","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0021-9150(98)00267-6","article-title":"Fine mapping of low-density lipoprotein receptor gene by genetic linkage on chromosome 19p13. 1-p13. 3 and study of the founder effect of four French Canadian low-density lipoprotein receptor gene mutations","volume":"143","author":"Couture","year":"1999","journal-title":"Atherosclerosis"},{"issue":"24","key":"10.1016\/j.phrs.2019.03.016_bib0080","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.2174\/138161211797247550","article-title":"Gene therapy for familial hypercholesterolemia","volume":"17","author":"Van Craeyveld","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.phrs.2019.03.016_bib0085","first-page":"D417","article-title":"Structural, biochemical and signaling properties of the low-density lipoprotein receptor gene family","volume":"6","author":"Hussain","year":"2001","journal-title":"Front Biosci"},{"issue":"3","key":"10.1016\/j.phrs.2019.03.016_bib0090","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s10517-013-2159-4","article-title":"\u201cFinnish\u201d mutations in LDL receptor gene: a rare cause of familial hypercholesterolemia in St. Petersburg and Petrozavodsk","volume":"155","author":"Komarova","year":"2013","journal-title":"Bull. Exp. Biol. Med."},{"issue":"6","key":"10.1016\/j.phrs.2019.03.016_bib0095","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1134\/S1022795413040066","article-title":"New mutations in low-density lipoprotein receptor gene in familial hypercholesterolemia patients from Petrozavodsk","volume":"49","author":"Komarova","year":"2013","journal-title":"Russ. J. Genet."},{"issue":"1","key":"10.1016\/j.phrs.2019.03.016_bib0100","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1755-7682-3-36","article-title":"LDLR-Gene therapy for familial hypercholesterolaemia: problems, progress, and perspectives","volume":"3","author":"Al-Allaf","year":"2010","journal-title":"Int. Arch. Med."},{"issue":"5","key":"10.1016\/j.phrs.2019.03.016_bib0105","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1172\/JCI112729","article-title":"In vivo evidence for reduced binding of low density lipoproteins to receptors as a cause of primary moderate hypercholesterolemia","volume":"78","author":"Vega","year":"1986","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.phrs.2019.03.016_bib0110","first-page":"823","article-title":"Characterization of autosomal dominant hypercholesterolemia caused by PCSK9 gain of function mutations and its specific treatment with alirocumab, a PCSK9 monoclonal antibody","volume":"8","author":"Hopkins","year":"2015","journal-title":"Circ. Genomic Precis. Med."},{"issue":"5","key":"10.1016\/j.phrs.2019.03.016_bib0115","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/MOL.0000000000000114","article-title":"PCSK9 and LDLR degradation: regulatory mechanisms in circulation and in cells","volume":"25","author":"Lagace","year":"2014","journal-title":"Curr. Opin. Lipidol."},{"issue":"2","key":"10.1016\/j.phrs.2019.03.016_bib0120","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ng1161","article-title":"Mutations in PCSK9 cause autosomal dominant hypercholesterolemia","volume":"34","author":"Abifadel","year":"2003","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.phrs.2019.03.016_bib0125","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12944-018-0763-z","article-title":"Spectrum of low-density lipoprotein receptor (LDLR) mutations in a cohort of Sri Lankan patients with familial hypercholesterolemia\u2013a preliminary report","volume":"17","author":"Paththinige","year":"2018","journal-title":"Lipids Health Dis."},{"issue":"2","key":"10.1016\/j.phrs.2019.03.016_bib0130","first-page":"169","article-title":"Familial hypercholesterolemia","volume":"33","author":"Bouhairie","year":"2015","journal-title":"Cardiol. Clin."},{"issue":"1","key":"10.1016\/j.phrs.2019.03.016_bib0135","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jacl.2013.09.004","article-title":"JCL roundtable: drug treatment of severe forms of familial hypercholesterolemia","volume":"8","author":"Brown","year":"2014","journal-title":"J. Clin. Lipidol."},{"issue":"1","key":"10.1016\/j.phrs.2019.03.016_bib0140","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1472-8206.2009.00764.x","article-title":"Combined therapy in the treatment of dyslipidemia","volume":"24","author":"Reiner","year":"2010","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2019.03.016_bib0145","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.atherosclerosis.2015.05.022","article-title":"Statin therapy reduces plasma endothelin-1 concentrations: a meta-analysis of 15 randomized controlled trials","volume":"241","author":"Sahebkar","year":"2015","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.phrs.2019.03.016_bib0150","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11745-010-3517-x","article-title":"Simvastatin therapy reduces prooxidant-antioxidant balance: results of a placebo-controlled cross-over trial","volume":"46","author":"Parizadeh","year":"2011","journal-title":"Lipids"},{"key":"10.1016\/j.phrs.2019.03.016_bib0155","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.phrs.2015.10.013","article-title":"Statin therapy and plasma cortisol concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials","volume":"103","author":"Sahebkar","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2019.03.016_bib0160","doi-asserted-by":"crossref","DOI":"10.1038\/srep09902","article-title":"A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations","volume":"5","author":"Serban","year":"2015","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.phrs.2019.03.016_bib0165","first-page":"546","article-title":"Association between statin use and plasma d-dimer levels: a systematic review and meta-analysis of randomised controlled trials","volume":"114","author":"Sahebkar","year":"2015","journal-title":"Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.phrs.2019.03.016_bib0170","first-page":"523","article-title":"[Pravastatin, a new cholesterol synthesis inhibitor for lowering increased serum cholesterol]","volume":"47","author":"Hoppichler","year":"1992","journal-title":"Z. Gesamte Inn. Med."},{"issue":"6","key":"10.1016\/j.phrs.2019.03.016_bib0175","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s10557-013-6479-4","article-title":"New therapies targeting apoB metabolism for high-risk patients with inherited dyslipidaemias: what can the clinician expect?","volume":"27","author":"Sahebkar","year":"2013","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.phrs.2019.03.016_bib0180","first-page":"651","article-title":"Mipomersen and other therapies for the treatment of severe familial hypercholesterolemia","volume":"8","author":"Bell","year":"2012","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.phrs.2019.03.016_bib0185","series-title":"Metabolic Effects of Liver Replacement in Homozygous Familial Hypercholesterolemia, Transplantation Proceedings","first-page":"3815","author":"Cienfuegos","year":"1987"},{"issue":"11","key":"10.1016\/j.phrs.2019.03.016_bib0190","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/nm1195-1148","article-title":"A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia","volume":"1","author":"Grossman","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2019.03.016_bib0195","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.mehy.2015.11.010","article-title":"IDOL, inducible degrader of low-density lipoprotein receptor, serves as a potential therapeutic target for dyslipidemia","volume":"86","author":"Zhang","year":"2016","journal-title":"Med. Hypotheses"},{"issue":"7","key":"10.1016\/j.phrs.2019.03.016_bib0200","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/S0022-2275(20)39730-3","article-title":"Regulation of low density lipoprotein receptor gene expression in HepG2 and Caco2 cells by palmitate, oleate, and 25-hydroxycholesterol","volume":"36","author":"Srivastava","year":"1995","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.phrs.2019.03.016_bib0205","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0022-2275(20)37280-1","article-title":"Transcriptional and post-transcriptional regulation of LDL receptor gene expression in PMA-treated THP-1 cells by LDL-containing immune complexes","volume":"38","author":"Huang","year":"1997","journal-title":"J. Lipid Res."},{"issue":"4","key":"10.1016\/j.phrs.2019.03.016_bib0210","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/ATVBAHA.108.179564","article-title":"The LDL receptor","volume":"29","author":"Goldstein","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.phrs.2019.03.016_bib0215","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0021-9150(99)00155-0","article-title":"Cytotoxic cholesterol is generated by the hydrolysis of cytoplasmic cholesteryl ester and transported to the plasma membrane","volume":"146","author":"Kellner-Weibel","year":"1999","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.phrs.2019.03.016_bib0220","first-page":"184","article-title":"PCSK9: an enigmatic protease","volume":"1781","author":"Lopez","year":"2008","journal-title":"Biochim. et Biophys. Acta (BBA)-Mol. Cell Biol. Lipids"},{"issue":"6","key":"10.1016\/j.phrs.2019.03.016_bib0225","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1358\/dnp.2008.21.6.1246795","article-title":"Inhibition of PCSK9 as a novel strategy for the treatment of hypercholesterolemia","volume":"21","author":"Lopez","year":"2008","journal-title":"Drug News Perspect."},{"issue":"26","key":"10.1016\/j.phrs.2019.03.016_bib0230","doi-asserted-by":"crossref","first-page":"19720","DOI":"10.1074\/jbc.M110.123729","article-title":"The E3 ubiquitin ligase IDOL induces the degradation of the low density lipoprotein receptor family members VLDLR and ApoER2","volume":"285","author":"Hong","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2019.03.016_bib0235","doi-asserted-by":"crossref","DOI":"10.4103\/2277-9175.98152","article-title":"Viral and nonviral delivery systems for gene delivery","volume":"1","author":"Nayerossadat","year":"2012","journal-title":"Adv. Biomed. Res."},{"issue":"5","key":"10.1016\/j.phrs.2019.03.016_bib0240","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1056\/NEJM198308043090507","article-title":"Defective lipoprotein receptors and atherosclerosis: lessons from an animal counterpart of familial hypercholesterolemia","volume":"309","author":"Goldstein","year":"1983","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.phrs.2019.03.016_bib0245","doi-asserted-by":"crossref","first-page":"8437","DOI":"10.1073\/pnas.87.21.8437","article-title":"Temporary amelioration of hyperlipidemia in low density lipoprotein receptor-deficient rabbits transplanted with genetically modified hepatocytes","volume":"87","author":"Wilson","year":"1990","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"12","key":"10.1016\/j.phrs.2019.03.016_bib0250","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1073\/pnas.85.12.4421","article-title":"Correction of the genetic defect in hepatocytes from the Watanabe heritable hyperlipidemic rabbit","volume":"85","author":"Wilson","year":"1988","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5039","key":"10.1016\/j.phrs.2019.03.016_bib0255","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1126\/science.1722351","article-title":"Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR-deficient rabbits","volume":"254","author":"Grossman","year":"1991","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.phrs.2019.03.016_bib0260","first-page":"472","article-title":"A novel approach for introducing hepatocytes into the portal circulation","volume":"121","author":"Grossman","year":"1993","journal-title":"J. Lab. Clin. Med."},{"issue":"5","key":"10.1016\/j.phrs.2019.03.016_bib0265","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1089\/hum.1992.3.5-501","article-title":"Transplantation of genetically modified autologous hepatocytes into nonhuman primates: feasibility and short-term toxicity","volume":"3","author":"Grossman","year":"1992","journal-title":"Hum. Gene Ther."},{"issue":"2","key":"10.1016\/j.phrs.2019.03.016_bib0270","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0021-9258(18)48379-2","article-title":"Hepatocyte-directed gene transfer in vivo leads to transient improvement of hypercholesterolemia in low density lipoprotein receptor-deficient rabbits","volume":"267","author":"Wilson","year":"1992","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.phrs.2019.03.016_bib0275","first-page":"137","article-title":"Therapeutic approach to familial hypercholesterolemia by HVJ-liposomes in LDL receptor knockout mouse","volume":"10","author":"Tomita","year":"2002","journal-title":"Int. J. Mol. Med."},{"issue":"9","key":"10.1016\/j.phrs.2019.03.016_bib0280","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/sj.gt.3301953","article-title":"Intravenous gene therapy for familial hypercholesterolemia using ligand-facilitated transfer of a liposome: LDL receptor gene complex","volume":"10","author":"Shichiri","year":"2003","journal-title":"Gene Ther."},{"issue":"6","key":"10.1016\/j.phrs.2019.03.016_bib0285","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/jgm.1041","article-title":"Delivery and long\u2010term expression of a 135 kb LDLR genomic DNA locus in vivo by hydrodynamic tail vein injection","volume":"9","author":"Hibbitt","year":"2007","journal-title":"J. Gene Med."},{"issue":"2","key":"10.1016\/j.phrs.2019.03.016_bib0290","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/sj.gt.3302865","article-title":"Structural impact of hydrodynamic injection on mouse liver","volume":"14","author":"Suda","year":"2007","journal-title":"Gene Ther."},{"issue":"2","key":"10.1016\/j.phrs.2019.03.016_bib0295","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/mt.2009.249","article-title":"Long-term physiologically regulated expression of the low-density lipoprotein receptor in vivo using genomic DNA mini-gene constructs","volume":"18","author":"Hibbitt","year":"2010","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.phrs.2019.03.016_bib0300","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/gt.2011.103","article-title":"RNAi-mediated knockdown of HMG CoA reductase enhances gene expression from physiologically regulated low-density lipoprotein receptor therapeutic vectors in vivo","volume":"19","author":"Hibbitt","year":"2012","journal-title":"Gene Ther."},{"issue":"2","key":"10.1016\/j.phrs.2019.03.016_bib0305","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.biochi.2006.09.015","article-title":"De novo cholesterol synthesis at the crossroads of adaptive response to extracellular stress through SREBP","volume":"89","author":"Robichon","year":"2007","journal-title":"Biochimie"},{"issue":"2","key":"10.1016\/j.phrs.2019.03.016_bib0310","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.gendis.2017.04.001","article-title":"Adenovirus-mediated gene delivery: potential applications for gene and cell-based therapies in the new era of personalized medicine","volume":"4","author":"Lee","year":"2017","journal-title":"Genes Dis."},{"issue":"2","key":"10.1016\/j.phrs.2019.03.016_bib0315","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1172\/JCI116663","article-title":"Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery","volume":"92","author":"Ishibashi","year":"1993","journal-title":"J. Clin. Invest."},{"issue":"18","key":"10.1016\/j.phrs.2019.03.016_bib0320","doi-asserted-by":"crossref","first-page":"13695","DOI":"10.1016\/S0021-9258(17)36886-2","article-title":"In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses","volume":"269","author":"Kozarsky","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2019.03.016_bib0325","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/ng0596-54","article-title":"J.F. Strauss III, J.M. Wilson, Effective treatment of familial hypercholesterolaemia in the mouse model using adenovirus\u2013mediated transfer of the VLDL receptor gene","volume":"13","author":"Kozarsky","year":"1996","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.phrs.2019.03.016_bib0330","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1172\/JCI117725","article-title":"In vivo gene therapy for hyperlipidemia: phenotypic correction in Watanabe rabbits by hepatic delivery of the rabbit LDL receptor gene","volume":"95","author":"Li","year":"1995","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.phrs.2019.03.016_bib0335","doi-asserted-by":"crossref","first-page":"e000519","DOI":"10.1161\/JAHA.113.000519","article-title":"Coronary heart disease risks associated with high levels of HDL cholesterol","volume":"3","author":"Wilkins","year":"2014","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"10.1016\/j.phrs.2019.03.016_bib0340","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.drudis.2017.09.014","article-title":"HDL functionality in familial hypercholesterolemia: effects of treatment modalities and pharmacological interventions","volume":"23","author":"Ganjali","year":"2018","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.phrs.2019.03.016_bib0345","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.plipres.2017.05.001","article-title":"HDL abnormalities in familial hypercholesterolemia: focus on biological functions","volume":"67","author":"Ganjali","year":"2017","journal-title":"Prog. Lipid Res."},{"issue":"6","key":"10.1016\/j.phrs.2019.03.016_bib0350","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00109-011-0722-x","article-title":"Regression and stabilization of advanced murine atherosclerotic lesions: a comparison of LDL lowering and HDL raising gene transfer strategies","volume":"89","author":"Van Craeyveld","year":"2011","journal-title":"J. Mol. Med."},{"issue":"2","key":"10.1016\/j.phrs.2019.03.016_bib0355","first-page":"166","article-title":"Non\u2010physiological overexpression of the low density lipoprotein receptor (LDLr) gene in the liver induces pathological intracellular lipid and cholesterol storage","volume":"6","author":"Cichon","year":"2004","journal-title":"J. Gene Med. Cross Discip. J. Res. Sci. Gene Transf. Clin. Appl."},{"issue":"2","key":"10.1016\/j.phrs.2019.03.016_bib0360","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.atherosclerosis.2008.02.023","article-title":"Adenoviral low density lipoprotein receptor attenuates progression of atherosclerosis and decreases tissue cholesterol levels in a murine model of familial hypercholesterolemia","volume":"201","author":"Jacobs","year":"2008","journal-title":"Atherosclerosis"},{"issue":"20","key":"10.1016\/j.phrs.2019.03.016_bib0365","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/sj.gt.3302310","article-title":"Low-density lipoprotein receptor gene therapy using helper-dependent adenovirus produces long-term protection against atherosclerosis in a mouse model of familial hypercholesterolemia","volume":"11","author":"Nomura","year":"2004","journal-title":"Gene Ther."},{"issue":"1","key":"10.1016\/j.phrs.2019.03.016_bib0370","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/sj.gt.3300796","volume":"6","author":"Pakkanen","year":"1999","journal-title":"Gene Ther."},{"issue":"3","key":"10.1016\/j.phrs.2019.03.016_bib0375","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/mt.2009.319","article-title":"Recent advances in lentiviral vector development and applications","volume":"18","author":"M\u00e1trai","year":"2010","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.phrs.2019.03.016_bib0380","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ymthe.2004.01.015","article-title":"Long-term lowering of plasma cholesterol levels in LDL-receptor-deficient WHHL rabbits by gene therapy","volume":"9","author":"Kankkonen","year":"2004","journal-title":"Mol. Ther."},{"issue":"15","key":"10.1016\/j.phrs.2019.03.016_bib0385","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1093\/nar\/gkm570","article-title":"An S\/MAR-based infectious episomal genomic DNA expression vector provides long-term regulated functional complementation of LDLR deficiency","volume":"35","author":"Lufino","year":"2007","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.phrs.2019.03.016_bib0390","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40259-017-0234-5","article-title":"Adeno-associated virus (AAV) as a vector for gene therapy","volume":"31","author":"Naso","year":"2017","journal-title":"BioDrugs"},{"issue":"6","key":"10.1016\/j.phrs.2019.03.016_bib0395","first-page":"663","article-title":"Gene therapy with novel adeno\u2010associated virus vectors substantially diminishes atherosclerosis in a murine model of familial hypercholesterolemia","volume":"6","author":"Lebherz","year":"2004","journal-title":"J. Gene Med. Cross Discip. J. Res. Sci. Gene Transf. Clin. Appl."},{"issue":"10","key":"10.1016\/j.phrs.2019.03.016_bib0400","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013424","article-title":"Gene therapy in a humanized mouse model of familial hypercholesterolemia leads to marked regression of atherosclerosis","volume":"5","author":"Kassim","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.phrs.2019.03.016_bib0405","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/hum.2012.108","article-title":"Adeno-associated virus serotype 8 gene therapy leads to significant lowering of plasma cholesterol levels in humanized mouse models of homozygous and heterozygous familial hypercholesterolemia","volume":"24","author":"Kassim","year":"2012","journal-title":"Hum. Gene Ther."},{"issue":"6","key":"10.1016\/j.phrs.2019.03.016_bib0410","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1161\/CIRCRESAHA.115.304008","article-title":"AAV vectors expressing LDLR gain-of-function variants demonstrate increased efficacy in mouse models of familial hypercholesterolemia","volume":"115","author":"Somanathan","year":"2014","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.phrs.2019.03.016_bib0415","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"issue":"35","key":"10.1016\/j.phrs.2019.03.016_bib0420","doi-asserted-by":"crossref","first-page":"4518","DOI":"10.2174\/0929867324666171012111603","article-title":"Autologous cell therapy for vascular regeneration: the role of proangiogenic cells","volume":"25","author":"Bianconi","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.phrs.2019.03.016_bib0425","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.pharmthera.2017.08.004","article-title":"Endothelial and cardiac progenitor cells for cardiovascular repair: a controversial paradigm in cell therapy","volume":"181","author":"Bianconi","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2019.03.016_bib0430","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6940283","article-title":"Stem cells applications in regenerative medicine and disease therapeutics","volume":"2016","author":"Mahla","year":"2016","journal-title":"Int. J. Cell Biol."},{"issue":"11","key":"10.1016\/j.phrs.2019.03.016_bib0435","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/cr.2009.107","article-title":"Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells","volume":"19","author":"Song","year":"2009","journal-title":"Cell Res."},{"key":"10.1016\/j.phrs.2019.03.016_bib0440","article-title":"JD\u2019iPS cell-derived hepatocytes faithfully recapitulate the pathophysiology of familial hypercholesterolemia","author":"GuoCayo","year":"2012","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.phrs.2019.03.016_bib0445","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1172\/JCI43122","article-title":"Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells","volume":"120","author":"Rashid","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.phrs.2019.03.016_bib0450","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s12033-012-9635-3","article-title":"Disease-corrected hepatocyte-like cells from familial hypercholesterolemia-induced pluripotent stem cells","volume":"54","author":"Fattahi","year":"2013","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.phrs.2019.03.016_bib0455","doi-asserted-by":"crossref","first-page":"13231","DOI":"10.1038\/srep13231","article-title":"Restoration of physiologically responsive low-density lipoprotein receptor-mediated endocytosis in genetically deficient induced pluripotent stem cells","volume":"5","author":"Ramakrishnan","year":"2015","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.phrs.2019.03.016_bib0460","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1089\/ten.tea.2008.0351","article-title":"Human embryonic stem cell\u2013derived mesoderm-like epithelium transitions to mesenchymal progenitor cells","volume":"15","author":"Boyd","year":"2009","journal-title":"Tissue Eng. Part A"},{"issue":"11","key":"10.1016\/j.phrs.2019.03.016_bib0465","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/nbt.3011","article-title":"Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases","volume":"32","author":"Citorik","year":"2014","journal-title":"Nat. Biotechnol."},{"issue":"11","key":"10.1016\/j.phrs.2019.03.016_bib0470","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/nbt.3043","article-title":"Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials","volume":"32","author":"Bikard","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.phrs.2019.03.016_bib0475","doi-asserted-by":"crossref","first-page":"44624","DOI":"10.1038\/srep44624","article-title":"Somatic genome editing with CRISPR\/Cas9 generates and corrects a metabolic disease","volume":"7","author":"Jarrett","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.phrs.2019.03.016_bib0480","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.cell.2014.09.014","article-title":"CRISPR-Cas9 knockin mice for genome editing and cancer modeling","volume":"159","author":"Platt","year":"2014","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.phrs.2019.03.016_bib0485","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/hep4.1110","article-title":"CRISPR correction of a homozygous low\u2010density lipoprotein receptor mutation in familial hypercholesterolemia induced pluripotent stem cells","volume":"1","author":"Omer","year":"2017","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.phrs.2019.03.016_bib0490","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-04048-4","article-title":"RNA-guided transcriptional silencing in vivo with S. Aureus CRISPR-Cas9 repressors","volume":"9","author":"Thakore","year":"2018","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.phrs.2019.03.016_bib0495","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/00000658-199602000-00002","article-title":"Safety and feasibility of liver-directed ex vivo gene therapy for homozygous familial hypercholesterolemia","volume":"223","author":"Raper","year":"1996","journal-title":"Ann. Surg."},{"issue":"5","key":"10.1016\/j.phrs.2019.03.016_bib0500","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11883-016-0579-0","article-title":"Recent developments in gene therapy for homozygous familial hypercholesterolemia","volume":"18","author":"Ajufo","year":"2016","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.phrs.2019.03.016_bib0505","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.atherosclerosis.2016.08.018","volume":"253","author":"Authors\/Task Force","year":"2016","journal-title":"Atherosclerosis"},{"issue":"19","key":"10.1016\/j.phrs.2019.03.016_bib0510","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jacc.2014.01.063","article-title":"Lipoprotein (a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation","volume":"63","author":"Alonso","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.phrs.2019.03.016_bib0515","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.atherosclerosis.2012.02.019","article-title":"Homozygous familial hypercholesterolemia: current perspectives on diagnosis and treatment","volume":"223","author":"Raal","year":"2012","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.phrs.2019.03.016_bib0520","doi-asserted-by":"crossref","first-page":"94","DOI":"10.5551\/jat.14.94","article-title":"Long-term outcome after living donor liver transplantation for two cases of homozygous familial hypercholesterolemia from a heterozygous donor","volume":"14","author":"Kawagishi","year":"2007","journal-title":"J. Atheroscler. Thromb."},{"issue":"2","key":"10.1016\/j.phrs.2019.03.016_bib0525","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s12016-017-8611-x","article-title":"MicroRNAs: New Therapeutic Targets for Familial Hypercholesterolemia?","volume":"54","author":"Momtazi","year":"2018","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"10","key":"10.1016\/j.phrs.2019.03.016_bib0530","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s001099900045","article-title":"Nonphysiological overexpression of low-density lipoprotein receptors causes pathological intracellular lipid accumulation and the formation of cholesterol and cholesteryl ester crystals in vitro","volume":"77","author":"Heeren","year":"1999","journal-title":"J. Mol. Med."},{"issue":"5","key":"10.1016\/j.phrs.2019.03.016_bib0535","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S1525-0016(03)00060-1","article-title":"Infectious delivery of a 135-kb LDLR genomic locus leads to regulated complementation of low-density lipoprotein receptor deficiency in human cells","volume":"7","author":"Wade-Martins","year":"2003","journal-title":"Mol. Ther."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661818319133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661818319133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:58:44Z","timestamp":1760911124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661818319133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":107,"alternative-id":["S1043661818319133"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2019.03.016","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review of gene- and cell-based therapies for familial hypercholesterolemia","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2019.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}